Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-06-30
2009-11-03
Kemmerer, Elizabeth C. (Department: 1646)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S002600, C530S350000
Reexamination Certificate
active
07612040
ABSTRACT:
The disclosure relates to Lefty derivatives and the uses of Lefty polypeptides as antagonists of the function of certain ligands such as Nodal, GDF-8 (Myostatin), and GDF-11. These derivatives may be fused to other functional heterologous proteins such as IgG, especially the Fc portion of IgG. According to the disclosure, Lefty polypeptides are useful in the treatment of a variety of disorders, including, for example, neuronal diseases, muscle and bone conditions, and metabolic disorders.
REFERENCES:
patent: 5916751 (1999-06-01), Tabibzadeh et al.
patent: 6027917 (2000-02-01), Celeste et al.
patent: 6294662 (2001-09-01), Tabibzadeh
patent: 6428966 (2002-08-01), Lee et al.
patent: 6440694 (2002-08-01), Bienkowski et al.
patent: 6492493 (2002-12-01), Murray et al.
patent: 6635480 (2003-10-01), Lee et al.
patent: 6649588 (2003-11-01), Tabibzadeh et al.
patent: 6673341 (2004-01-01), Sukhatme
patent: 6683156 (2004-01-01), Tabibzadeh
patent: 6747004 (2004-06-01), Tabibzadeh
patent: 7355018 (2008-04-01), Glass
patent: 2002/0086351 (2002-07-01), Ebner et al.
patent: 2003/0022841 (2003-01-01), Lee et al.
patent: 2003/0032047 (2003-02-01), Tabibzadeh
patent: 2003/0149241 (2003-08-01), Celeste et al.
patent: 2004/0081647 (2004-04-01), Afeyan et al.
patent: 2004/0146891 (2004-07-01), Lee et al.
patent: WO-02/12336 (2002-02-01), None
Wells, 1990, Biochemistry 29:8509-8517.
Ngo et al., 1994, The Protein Folding Problem and Tertiary Structure Prediction, Merz et al., eds., Birkhauser, Boston, pp. 492-495.
Bork, 2000, Genome Research 10:398-400.
Skolnick et al., 2000, Trends in Biotech. 18(1):34-39.
Doerks et al., 1998, Trends in Genetics 14:248-250.
Smith et al., 1997, Nature Biotechnology 15:1222-1223.
Brenner, 1999, Trends in Genetics 15:132-133.
Bork et al., 1996, Trends in Genetics 12:425-427.
Branford et al., “Nodal Signaling: Cryptic Lefty Mechanism of Antagonism Decoded”, Current Biology, 14:R341-R343 (1994).
Chen et al., “The Vg1-related protein Gdf3 acts in a Nodal signaling pathway in the pre-gastrulation mouse embryo”, Development, 133:319-329 (2005).
Chen et al., “Two Modes by which Lefty Proteins Inhibit Nodal Signaling”, Current Biology, 14:618-624 (2004).
Cheng et al., “Lefty Blocks a subset of TGFβ Signals by Antagonizing EGF-CFC Coreceptors”, PLoS Biology, 2:2:0215-0226 (2004).
Kosaki et al., “Characterization and mutation analysis of humanLEFTY AandLEFTY B, homologues of murine genes implicated in left-right axis development,” Am. J. Hum. Genet. 64:712-721 (1999).
Kothapalli et al., “Detection of ebaf, a Novel Human Gene of the Transforming Growth Factor β Superfamily”, The American Society for Clinical Investigation, Inc., 99:2342-2350 (1997).
Lapraz et al., “RTK and TGF-β signaling pathways genes in the sa urchin genome,” Developmental Biology, 300:132-152 (2006).
Mason et al., “Lefty Contributes to the Remodeling of Extracellular Matrix by Inhibition of Connective Tissue Growth Factor and Collagen mRNA Expression and Increased Proteolytic Activity in a Fibrosarcoma Model”, The Journal of Biological Chemistry, 277:407-415 (2002).
Meno et al., “Diffusion of Nodal Signaling Activity in the Absense of the Feedback Inhibitor Lefty2”, Developmental Cell, 1:127-138 (2001).
Oulad-Abdelghani et al., “lefty, a retinoic acid-inducible novel member of the transforming growth factorβ superfamily”, Int. J. Dev. Biol., 42:23-32 (1998).
Rankin et al., “Regulation of left-right patterning in mice by growth/differentiation factor-1”, Nature Genetics, 24:262-265 (2000).
Saijoh et al., “Distinct transcriptional regulatory mechanisms underlie left-right asymmetric expression of lefty-1 and lefty-2”, Genes & Development, 13:259-269 (1999).
Sakuma et al., “Inhibition of Nodal signalling by Lefty mediated through interaction with common receptors and efficient diffusion”, Genes to Cells, 7:401-412 (2002).
Tabibzadeh et al., “Lefty at the crossroad of ‘stemness’ and differentiative events”, Stem Cells, www.StemCells.com, DOI: 10.1634/stemcells, (2006).
Ulloa et al., “Lefty Inhibits Receptor-regulated Smad Phosphorylation Induced by the Activated Transforming Growth Factor-β Receptor”, The Journal of Biological Chemistry, 276:21397-21404 (2001).
Knopf John
Kumar Ravindra
Seehra Jasbir
Acceleron Pharma Inc.
Kemmerer Elizabeth C.
Ropes & Gray LLP
LandOfFree
Lefty polypeptides and derivatives thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Lefty polypeptides and derivatives thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lefty polypeptides and derivatives thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4118665